Company

ARROWHEAD PHARMACEUTICALS, INC.

ARWR · CIK 0000879407

SEC FORM 4

$173,920.00

Sale of 2,000 shares at $86.96 per share.

Reporting Person OLUKOTUN ADEOYE Y · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001242615-26-000002 · filed 2026-08-20 · View filing →

SEC FORM 4

$1,012,680.00

Sale of 11,600 shares at $87.30 per share.

Reporting Person PERRY MICHAEL S · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001250379-26-000002 · filed 2026-08-20 · View filing →